Data de publicação: 24/03/2022 - 15:43
At a meeting that took place last Friday (March 19), representatives of Fiocruz and of the Deutsche Forschungsgemeinschaft (DFG), a German non-profit organization that stimulates research, got together to strengthen bilateral cooperation between the institutions and to discuss possible foment partnerships. As a first step in this direction, a workshop was suggested to evaluate the opportunities, identifying possibilities among ongoing projects...
Notícias
Data de publicação: 23/03/2022 - 16:44
Unitaid, the global health agency connected to the WHO, will be financing the implementation of the project for Injectable Pre-Exposure Prophylaxy in Brazil, using long-acting Cabotegravir. With only six injections per year, the method has proven to be more effective than daily oral PrEP in terms of reducing the risk of infection by the virus. The project will be coordinated by the Evandro Chagas National Infectiology Institute (INI/Fiocruz) in...
Notícias
Data de publicação: 23/03/2022 - 16:42
A study by researchers of Fiocruz and of the University of Columbia has identified promising results in a combination of antiviral drugs for the treatment of COVID-19. Scientists showed that there is a synergy between the substances, inhibiting the enzymes that allow Sars-CoV-2 to multiply more effectively. Together, the drugs may reduce viral replication about ten times more than if taken separately.
The drugs studied are already...
Notícias
Data de publicação: 21/03/2022 - 17:54
The war in Ukraine has been thoroughly divulged, discussed, and explained on all social media platforms, in Brazil and abroad. Its geopolitical, economic, and social consequences have also been explored by specialists of all fields of knowledge and geographical position. However, there is one dimension that has been left out by this widely encompassing debate: the matter of health.
On the other hand, more attentive readers will certainly not...
Notícias
Data de publicação: 21/03/2022 - 12:54
Diseases transmitted from animals to humans, such as spotted fever, Q fever, hantavirus diseases, and arenavirus diseases present early clinical symptoms that are similar to those of other infections, including fever, headache, or aches in the body, and malaise. Amidst an epidemic, when all eyes are focused on diseases that are circulating widely, such as dengue fever or Covid-19, these zoonoses are often forgotten when diagnosing a patient....
Notícias
Data de publicação: 16/03/2022 - 14:24
The Global Network of Human Milk Banks (rBLH) has already started organizing the celebrations of World Human Milk Donation Day - 19 May. The first step consists in choosing the slogan for social mobilization for the donation of human milk in 2022.
Applications must be submitted between the 14th and the 25th of March.
“Human Milk Donation: Solidarity and Peace in a Globalized World” is the theme of social mobilization chosen for...
Notícias
Data de publicação: 16/03/2022 - 11:20
Through the Institute of Drug Technology (Farmanguinhos) and French laboratory Servier, Fiocruz signed, last Thursday (March 10th), a Memorandum of Understanding for technical cooperation to develop new drugs against chronic diseases, from a new pharmaceutical platform. This is an innovative technology based on the prolonged release of the active ingredient in the body, resulting in efficacy, safety, and more compliance and practicality for...
Notícias
Data de publicação: 15/03/2022 - 13:35
In reference to International Women’s Day, the Pasteur Institute, in Paris, paid homage to five female scientists that are part of the institution's international scientific cooperation network. Among them, representing the Americas, was researcher Teca Galvão, from the Laboratory for Functional Genomics and Bioinformatics of the Oswaldo Cruz Institute (IOC/Fiocruz).
The homage highlighted the specialist’s education,...
Notícias
Data de publicação: 14/03/2022 - 12:25
An article published in Nature Biomedical Engineering, last Monday (March 7th), reveals the potential use of synthetic biosensors in rapid, decentralized, and low-cost tests for the diagnosis of patients infects with the zika virus. The study was led by scientists of the University of Toronto (CA), who developed the sensors and the portable digital platform where samples are processed, and had the partnership of researchers from Fiocruz...
Notícias
Data de publicação: 14/03/2022 - 11:43
March is celebrated as the month of International Women’s Day, but it is also the time to debate gender inequalities and guarantee of rights. This issue was highlighted by the ambassador of UN Women for Latin America, María del Carmen Squeff, at the Advanced Seminar in Global Health and Health Diplomacy of the Fiocruz Global Health Center (CRIS/Fiocruz), last Wednesday (March 9th). At the event, which was attended by researchers in...
Notícias
Data de publicação: 11/03/2022 - 12:25
During a conference in London, attended by the world’s most prominent health authorities and specialists, Fiocruz president, Nísia Trindade Lima, emphasized the need to decentralize vaccine production and to strengthen investments in research and development, in order to reduce inequalities between countries. Her statement was made during the Global Summit for Preparation for Pandemics, last Tuesday (March 8th). Organized by the...
Notícias
Data de publicação: 08/03/2022 - 15:43
Vaccination can protect the population against contamination, hospitalization, and death by COVID-19, even in socially vulnerable communities with high transmission rates. This is one of the main conclusions of a new paper of the "Vacina Maré" (vaccinate Maré, in english) research, which evaluates the effectiveness of the Fiocruz/AstraZeneca vaccine against getting sick with COVID-19, in Complexo da Maré, a complex...
Notícias
Data de publicação: 03/03/2022 - 13:20
Countries with high vaccination coverage are adopting a dangerous rhetoric according to which the pandemic is over or almost over. But how can one state that when there are still 70,000 people dying of COVID-19 in a week, worldwide? The warning was issued by the Assistant Director-General for Access to Medicines and Pharmaceutical Products of the World Health Organization (WHO), Brazilian Mariângela Batista Galvão Simão. At...
Notícias
Data de publicação: 25/02/2022 - 16:17
When he was about to turn 4 years old, Julinho started to attend a day care center near his home. The adaptation was difficult for the adults in the family, who were used to taking care of him all the time. “What if he had a seizure?”, “What if he cried a lot?”, “What if they forgot the medication schedule?”. The questions were frequent. But the boy surprised everyone with his good integration: he didn't...
Notícias
Data de publicação: 25/02/2022 - 15:01
In this role for less than five months, the new Ecuador ambassador in Brazil, Carlos Alberto Velástegui, visited Fiocruz last Friday (February 18) to strengthen the ties between his country and the Foundation. In the company of consul Marco Larrea, he was welcomed by Fiocruz president, Nísia Trindade Lima, and showed interest in defining areas for possible cooperation with Ecuador institutions and in getting to know more about the...
Notícias
Data de publicação: 22/02/2022 - 16:51
The Oswaldo Cruz Foundation (Fiocruz), through the Immunobiological Technology Institute (Biomanguinhos), provides the first doses of the COVID-19 vaccine (recombinant) produced with the national Active Pharmaceutical Ingredient (API). The first batch of national vaccines was released by the internal quality control of Bio-Manguinhos on 2/14.
“The release of the first 100% Brazilian COVID-19 vaccines, now available to the Ministry of...
Notícias
Data de publicação: 22/02/2022 - 14:33
This Thursday (17/2) the Fiocruz Genomic Network released new figures on the lineages and variants of the Sars-CoV-2 virus in Brazil. The data are computed every week on the Network’s platform, using data obtained from the EpiCoV platform, from GISAID (Global Initiative on Sharing All Influenza Data), an international platform used to share the genomic data of influenza and Sars-CoV-2 viruses.
The Fiocruz Genomic Network site gathers...
Notícias
Data de publicação: 16/02/2022 - 16:01
A technological innovation may contribute to the quest for the leprosy elimination, one of the humanity oldest diseases. An international team of scientists, led by the Oswaldo Cruz Institute (IOC/Fiocruz), in partnership with Microsoft AI for Health and the Novartis Foundation, has developed a diagnostic assistant, based on artificial intelligence, which can help identify suspected leprosy lesions. The technology has been called AI4Leprosy...
Notícias
Data de publicação: 15/02/2022 - 14:38
Looking at the map, the distance between the countries is big. Within the American continent, Mexico is the Spanish-speaking country that is farthest away from Brazil. But the two nations are closer to each other than it may seem. Fiocruz and Mexican institutions have joint projects, a cooperation that can expand even further, judging by the interest demonstrated by consul Héctor Humberto Valezzi Zafra. Together with the deputy consul in...
Notícias
Data de publicação: 15/02/2022 - 12:19
COVID-19 diagnostics, therapeutics, and vaccines are powerful reminders: health technologies can help to shape the way in which societies control disease. Challenges in ensuring global, equitable access to these fruits of biomedical research and development (R&D) during the COVID-19 pandemic have highlighted the urgency of reorienting the system towards the public interest. The first step is a clearer articulation of what R&D in the...
Notícias
Data de publicação: 15/02/2022 - 10:42
In a geopolitical context marked by disputes and inequalities, there are many economic, social, and environmental challenges in the path of those aiming to reduce these inequalities and achieve better global health outcomes. Based on this point of view, issues such as multilateralism and a possible new world order were discussed last Thursday (February 10) during the first Advanced Seminar in Global Health and Health Diplomacy this year....
Notícias
Data de publicação: 09/02/2022 - 17:07
A study analyzed the geographic distribution and the incidence of co-infection with a human T-lymphotropic virus (HTLV) and a human immunodeficiency virus (HIV) in Bahia, which is an endemic state for both retroviruses. The research was carried out using all samples submitted to serological tests at the Central Public Health Laboratory of Bahia (Lacen-BA), from 2004 to 2013. The total was about 130,000 samples from 358 of the 417 municipalities...
Notícias
Data de publicação: 08/02/2022 - 16:21
As reported by the State Health Secretariats of Rio de Janeiro and Santa Catarina, Fiocruz has identified three cases of the BA.2 lineage of the Omicron variant, using genetic sequencing. Two of the cases occurred in Rio de Janeiro and the other in the southern state of Santa Catarina. The findings were confirmed by the Laboratory of Measles and Respiratory Viruses of the Oswaldo Cruz Institute (IOC/Fiocruz), a national reference center for...
Notícias
Data de publicação: 08/02/2022 - 16:00
The Fiocruz Genomic Network has released new data on the status of lineages and variants of the Sars-CoV-2 in Brazil, based on the genomic surveillance produced by the Network and by other initiatives. According to the publication, while in December 39.4% of sequenced genomes belonged to the Omicron variant, in January 2022 this rate rose to 95.9%. The variant has now been found in all of the country’s regions. The Network Report shows...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
